Related references
Note: Only part of the references are listed.Colposcopic and histopathologic evaluation of women with HPV persistence exiting an organized screening program
Hanna Sahlgren et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2020)
Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: Concurrent cohorts with a 5-year follow-up
Manuel Zorzi et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation
Georgie Weston et al.
BMJ OPEN (2020)
HPV-mRNA and HPV-DNA detection in samples taken up to seven years before severe dysplasia of cervix uteri
Ola Forslund et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
HPV-based screening for cervical cancer among women 55-59 years of age
Lovisa Bergengren et al.
PLOS ONE (2019)
Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany
Thomas Iftner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Prevalence of High-risk HPV in Postmenopausal Women with Benign Cervical Cytology - A Population-based Cohort Study
Katrin Christine Asciutto et al.
ANTICANCER RESEARCH (2018)
HPV prevalence and HPV-related dysplasia in elderly women
Ruth S. Hermansson et al.
PLOS ONE (2018)
Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma
Ming-Zhe Wu et al.
CELL TRANSPLANTATION (2018)
Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial
Darrel A. Cook et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
Negative Pap tests in women with high-grade cervical lesions on follow-up biopsies: Contributing factors and role of human papillomavirus genotyping
Steven Goodman et al.
DIAGNOSTIC CYTOPATHOLOGY (2018)
Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
Jiangrong Wang et al.
PLOS MEDICINE (2017)
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
Maaike G. Dijkstra et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
Maaike G. Dijkstra et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
M. Arbyn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities
Hanna Johansson et al.
PLOS ONE (2015)
The Distribution of High-Risk Human Papillomaviruses Is Different in Young and Old Patients with Cervical Cancer
Mariano Guardado-Estrada et al.
PLOS ONE (2014)
Patterns of persistent genital human papillomavirus infection among women worldwide: A literature review and meta-analysis
Anne F. Rositch et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: A meta-analysis of the diagnostic accuracy
Marc Arbyn et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations From the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
Teresa M. Darragh et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2012)
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Marc Arbyn et al.
VACCINE (2012)
Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer
U. Gyllensten et al.
BRITISH JOURNAL OF CANCER (2011)
HPV mRNA tests for the detection of cervical intraepithelial neoplasia: A systematic review
E. A. Burger et al.
GYNECOLOGIC ONCOLOGY (2011)
HPV test shows low sensitivity of Pap screen in older women
Ulf Gyllensten et al.
LANCET ONCOLOGY (2010)
Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus
Anna Soederlund-Strand et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia
Kate Cuschieri et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Bead-based multiplex genotyping of human papillomaviruses
M Schmitt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica
PE Castle et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The 2001 Bethesda System - Terminology for reporting results of cervical cytology
D Solomon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Effects of age and human papilloma viral load on colposcopy triage: Data from the randomized atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study (ALTS)
ME Sherman et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica
R Herrero et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
